Chemomab Therapeutics Ltd. — Director's Dealing 2021

Apr 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Chemomab Therapeutics Ltd. (CMMB)
CIK: 0001534248
Period of Report: 2021-04-19

Reporting Person: SQUINTO STEPHEN P (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-19	Option to Purchase American Depositary Shares	$27.26	A	23768	Acquired	2031-04-19	American Depositary Shares (23768)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
American Depositary Shares	47938	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option to Purchase American Depositary Shares	$0.67	2025-11-18	American Depositary Shares (424)	424	Direct
Option to Purchase American Depositary Shares	$0.8	2026-09-13	American Depositary Shares (2109)	2109	Direct
Option to Purchase American Depositary Shares	$1.49	2027-11-19	American Depositary Shares (21095)	21095	Direct
Option to Purchase American Depositary Shares	$1.49	2028-10-21	American Depositary Shares (32928)	32928	Direct
Option to Purchase American Depositary Shares	$1.48	2030-11-19	American Depositary Shares (40362)	40362	Direct

Footnotes

F1: No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.

F2: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.

F3: These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service.

F4: These options have vested and are exercisable as of the date hereof, subject to the Reporting Person's continued service.

F5: 14,059 of these options to purchase ADSs have vested and are exercisable as of the date hereof, while the remaining 7,036 of these options will vest and become exercisable in three installments, with 1/3 of the options vesting on each three month anniversary commencing on May 16, 2021, subject to the Reporting Person's continued service.

F6: 5,042 of these options to purchase ADSs have vested and are exercisable as of the date hereof, while the remaining 35,320 of these options will vest and become exercisable in seven installments, with 1/7 of the options vesting on each three month anniversary commencing on May 19, 2021, subject to the Reporting Person's continued service.